Radiant Biotherapeutics, a Canadian biotech advancing multi-specific, multi-affinity antibody (Multabody) therapeutics in ...

Shares of US biopharma Rhythm Pharmaceuticals rose 27.4% to $82.96 in early trading today, as it announced positive top-line ...

The US Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for ...

US antivirals specialist Gilead Sciences today announced a strategic partnership agreement with the Global Fund to Fight AIDS ...

Radiopharmaceutical biotech Actithera today announced the close of an oversubscribed $75.5 million Series A financing round.

US pharma giant Merck & Co today revealed it has made a bid to acquire UK-based lung therapy company Verona Pharma, sending ...

Danish drugmaker Novo Nordisk (NOV: N) has filed for European approval of a higher-dose version of its obesity treatment ...

Dutch privately held Amarna Therapeutics, which specializes in transformative gene therapies announced the formalization of ...

French biotech Ciloa is joining the race to treat type 2 diabetes and obesity, armed with 6.5 million euros ($7.6 million) in ...

New Jersey, USA-headquartered Champions Oncology, a translational oncology research organization, yesterday announced the ...

US clinical-stage biotech ProKidney reported statistically-significant and clinically-meaningful positive top-line results ...

A new analysis from US data analytics firm Phesi has raised concerns about the viability of ongoing Phase III trials in ...